Literature DB >> 26277787

miR-211 promotes non-small cell lung cancer proliferation by targeting SRCIN1.

Leiguang Ye1, Hui Wang1, Baogang Liu2.   

Abstract

MicroRNAs (miRNAs) are a class of small non-coding RNAs that, when dysregulated, are involved in the initiation and progression of various cancers, including lung cancer, in humans. In the current study, qRT-PCR was performed to measure miR-211 expression in human non-small cell lung cancer (NSCLC) cell lines and tissues. Cell proliferation, cell cycle, colony formation, and invasion were performed to detect the functional role of miR-211 in human NSCLC cell line. We used luciferase reporter assay to find the potential target of miR-211. We found that miR-211 expression was upregulated in human non-small cell lung cancer (NSCLC) cell lines and tissues. The overexpression of miR-211 enhanced NSCLC cell proliferation, colony formation, and invasion. SRC kinase signaling inhibitor 1 (SRCIN1) was identified as a direct target of miR-211. SRCIN1 silencing promoted cell proliferation, and SRCIN1 expression was downregulated in human NSCLC cell lines. Thus, miR-211 may function as an oncogenic miRNA in NSCLC, partly by regulating SRCIN1, and the modulation of miR-211 expression represents a potential strategy for the treatment of NSCLC patients.

Entities:  

Keywords:  MiR-211; MicroRNA; Non-small cell lung cancer; SRCIN1

Mesh:

Substances:

Year:  2015        PMID: 26277787     DOI: 10.1007/s13277-015-3835-y

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  42 in total

1.  miR-150 promotes the proliferation and migration of lung cancer cells by targeting SRC kinase signalling inhibitor 1.

Authors:  Minghui Cao; Dongxia Hou; Hongwei Liang; Fei Gong; Yilei Wang; Xin Yan; Xiaohong Jiang; Chen Wang; Junfeng Zhang; Ke Zen; Chen-Yu Zhang; Xi Chen
Journal:  Eur J Cancer       Date:  2014-01-20       Impact factor: 9.162

2.  microRNA-137 functions as a tumor suppressor in human non-small cell lung cancer by targeting SLC22A18.

Authors:  Bicheng Zhang; Tao Liu; Tingting Wu; Zhigang Wang; Zhiguo Rao; Jianfei Gao
Journal:  Int J Biol Macromol       Date:  2014-12-11       Impact factor: 6.953

3.  MicroRNA-375 is downregulated in pancreatic cancer and inhibits cell proliferation in vitro.

Authors:  Jian Zhou; Shiduo Song; Jiannong Cen; Dongming Zhu; Dechun Li; Zixiang Zhang
Journal:  Oncol Res       Date:  2012       Impact factor: 5.574

4.  Analysis of hsa-miR-30a-5p expression in human gliomas.

Authors:  Kun Wang; Zhifan Jia; Jian Zou; Anling Zhang; Guangxiu Wang; Jianwei Hao; Yirong Wang; Shuxu Yang; Peiyu Pu
Journal:  Pathol Oncol Res       Date:  2013-04-20       Impact factor: 3.201

5.  MicroRNA-495 mimics delivery inhibits lung tumor progression.

Authors:  Cheng Ai; Rujian Jiang; Li Fu; Youdong Chen
Journal:  Tumour Biol       Date:  2014-10-07

Review 6.  MicroRNA dysregulation in uveal melanoma: a new player enters the game.

Authors:  Zheng Li; Xin Yu; Jianxiong Shen; Yang Jiang
Journal:  Oncotarget       Date:  2015-03-10

7.  Transcriptome-wide analysis of UTRs in non-small cell lung cancer reveals cancer-related genes with SNV-induced changes on RNA secondary structure and miRNA target sites.

Authors:  Radhakrishnan Sabarinathan; Anne Wenzel; Peter Novotny; Xiaojia Tang; Krishna R Kalari; Jan Gorodkin
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

8.  microRNA-99a is downregulated and promotes proliferation, migration and invasion in non-small cell lung cancer A549 and H1299 cells.

Authors:  Changjin Chen; Ziyi Zhao; Yu Liu; Dezhi Mu
Journal:  Oncol Lett       Date:  2015-01-14       Impact factor: 2.967

9.  miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.

Authors:  Bairong Xia; Shanshan Yang; Tianbo Liu; Ge Lou
Journal:  Mol Cancer       Date:  2015-03-11       Impact factor: 27.401

10.  miR-219-5p inhibits receptor tyrosine kinase pathway by targeting EGFR in glioblastoma.

Authors:  Soumya Alige Mahabala Rao; Arivazhagan Arimappamagan; Paritosh Pandey; Vani Santosh; Alangar Sathyaranjandas Hegde; Bangalore Ashwathnarayanara Chandramouli; Kumaravel Somasundaram
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

View more
  18 in total

1.  Midazolam induces A549 cell apoptosis in vitro via the miR-520d-5p/STAT3 pathway.

Authors:  Jinghua Jiao; Yuheng Wang; Xiaofeng Sun; Xiaojing Jiang
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

2.  MicroRNA-1304 suppresses human non-small cell lung cancer cell growth in vitro by targeting heme oxygenase-1.

Authors:  Cheng-Gang Li; Meng-Fan Pu; Chun-Zhu Li; Man Gao; Ming-Xia Liu; Cun-Zhi Yu; Hong Yan; Chun Peng; Yang Zhao; Yu Li; Ze-Long Ma; Xin-Ming Qi; Yi-Zheng Wang; Ling-Ling Miao; Jin Ren
Journal:  Acta Pharmacol Sin       Date:  2016-09-19       Impact factor: 6.150

3.  MiR-320a effectively suppresses lung adenocarcinoma cell proliferation and metastasis by regulating STAT3 signals.

Authors:  Qing Lv; Jin-Xia Hu; You-Jie Li; Ning Xie; Dan Dan Song; Wei Zhao; Yun-Fei Yan; Bao-Sheng Li; Ping-Yu Wang; Shu-Yang Xie
Journal:  Cancer Biol Ther       Date:  2017-01-20       Impact factor: 4.742

4.  Predictive relevance of miR-34a, miR-224 and miR-342 in patients with advanced squamous cell carcinoma of the lung undergoing palliative chemotherapy.

Authors:  Vlastimil Kulda; Martin Svaton; Petr Mukensnabl; Kristyna Hrda; Pavel Dvorak; Zbynek Houdek; Katerina Houfkova; Radana Vrzakova; Vaclav Babuska; Milos Pesek; Martin Pesta
Journal:  Oncol Lett       Date:  2017-11-02       Impact factor: 2.967

5.  Tumor suppressor miR-211-5p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma.

Authors:  Jing Quan; Xiang Pan; Tao He; Canbin Lin; Yulin Lai; Peijie Chen; Zeng Zhang; Shangqi Yang; Tao Wang; Yongqing Lai
Journal:  Exp Ther Med       Date:  2018-02-28       Impact factor: 2.447

6.  MicroRNA-211 promotes non-small-cell lung cancer proliferation and invasion by targeting MxA.

Authors:  Mafei Kang; Jieqiong Shi; Na Peng; Shaozhong He
Journal:  Onco Targets Ther       Date:  2017-11-28       Impact factor: 4.147

7.  SNP rs3202538 in 3'UTR region of ErbB3 regulated by miR-204 and miR-211 promote gastric cancer development in Chinese population.

Authors:  Yaxiang Shi; Xuan Chen; Biao Xi; Xiaowen Yu; Jun Ouyang; Chunxia Han; Yucheng Qin; Defeng Wu; Hong Shen
Journal:  Cancer Cell Int       Date:  2017-09-13       Impact factor: 5.722

8.  The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries.

Authors:  Silvia Grasso; Jennifer Chapelle; Vincenzo Salemme; Simona Aramu; Isabella Russo; Nicoletta Vitale; Ludovica Verdun di Cantogno; Katiuscia Dallaglio; Isabella Castellano; Augusto Amici; Giorgia Centonze; Nanaocha Sharma; Serena Lunardi; Sara Cabodi; Federica Cavallo; Alessia Lamolinara; Lorenzo Stramucci; Enrico Moiso; Paolo Provero; Adriana Albini; Anna Sapino; Johan Staaf; Pier Paolo Di Fiore; Giovanni Bertalot; Salvatore Pece; Daniela Tosoni; Stefano Confalonieri; Manuela Iezzi; Paola Di Stefano; Emilia Turco; Paola Defilippi
Journal:  Nat Commun       Date:  2017-03-16       Impact factor: 14.919

9.  miR-211-5p inhibits the proliferation, migration, invasion, and induces apoptosis of human hypertrophic scar fibroblasts by regulating TGFβR2 expression.

Authors:  Jun Tang; Jianing Yang; Hua Hu; Ying Cen; Junjie Chen
Journal:  Ann Transl Med       Date:  2021-05

10.  MicroRNA-211 suppresses prostate cancer proliferation by targeting SPARC.

Authors:  Peng Hao; Bo Kang; Guoqing Yao; Wenqi Hao; Feihong Ma
Journal:  Oncol Lett       Date:  2018-01-26       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.